Vraylar 1.5 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FFFE9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,689
Award facts
- Contract value 100% obligated
- $25,689.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $25,689.01 by the Defense Logistics Agency on August 26, 2025, for the supply of Vraylar 1.5 mg capsules (30-count units). The contract employs firm fixed pricing and carries an ultimate completion date of August 27, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Vraylar is a neurological medication used in the treatment of certain psychiatric conditions and represents one of many pharmaceutical products delivered by AmerisourceBergen through its federal contract portfolio.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare systems worldwide. Through this and related federal contracts, AmerisourceBergen supports critical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, demonstrating the company's established capability to meet federal medical supply requirements through open competition.
Quick answers
Who was awarded contract SPE2DB25FFFE9?
SPE2DB25FFFE9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FFFE9 worth?
The government has obligated $25,689 on SPE2DB25FFFE9.
Is contract SPE2DB25FFFE9 an order under another contract?
Yes. SPE2DB25FFFE9 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FFFE9 competed?
The extent of competition for SPE2DB25FFFE9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award